About Meha Pharma
Meha Pharma is a Chemicals & Materials company. It operates as a manufacturer of antacid APIs and excipients in India. It operates in the Chemicals & Materials and Healthcare sectors. Its Indian entity Meha Pharma Private Limited reported revenue of ₹11.43 Cr. Meha Pharma offers products and services including Antacid API and Excipients. Its focus areas include Chemicals, Speciality Chemicals, Silicates and Simethicones and Pharmaceuticals.
Company details
Meha Pharma is identified as the largest manufacturer and exporter of antacid APIs in India, with facilities situated in Goa and an office in Mumbai. Products including antacid actives, excipients, and speciality chemicals are produced under cGMP conditions, serving pharmaceuticals, cosmetics, nutraceutical, and food industries across 22 countries. Customization for parameters like bulk density and particle size is offered, while solutions for formulation issues such as discoloration and settling are provided. Safety and efficacy standards are maintained by the company to meet regulatory expectations, focusing on high-quality materials for global markets.
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Social LinkedIn Facebook
- Legal Name Meha Pharma Private Limited
- Date of Incorporation 16 Apr, 2023
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹11.43 Cr
FY 2024
- Net Profit₹31.2 Lakh
FY 2024 · 3% margin
- EBITDA₹1.49 Cr
FY 2024 · 13% margin
Associated legal entities of Meha Pharma
Meha Pharma operates through Meha Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Meha Pharma Private Limited CIN U46497MH2023PTC400839 | Active | 16 Apr 2023 | Mumbai, Maharashtra | ₹11.4 Cr | – | 2 | View details |
Products & Services of Meha Pharma
Meha Pharma offers a comprehensive portfolio of products and services, including Antacid API and Excipients.
Antacid active pharmaceutical ingredients are produced and exported by the company for use in medications
Excipients such as Aluminium Hydroxide and Magnesium Hydroxide are manufactured by the company for applications in pharmaceuticals and cosmetics
Board of directors of Meha Pharma Private Limited (Meha Pharma)
Meha Pharma Private Limited is the primary company behind Meha Pharma. The board of Meha Pharma Private Limited currently have 2 directors; the longest-serving is Mamta Agarwal, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mamta Agarwal DIN 00273534 | Director | 16 Apr 2023 | 3 yrs 6 mo | Meha Pharma Private Limited |
| Sanjay Kailashchandra Agarwal DIN 00273468 | Director | 16 Apr 2023 | 3 yrs 6 mo | Meha Pharma Private Limited |
Financials of Meha Pharma
Figures of Meha Pharma Private Limited, the primary company behind Meha Pharma, for FY 2024. Revenue was ₹11.43 Cr. Net profit was ₹31.2 Lakh (3% margin). EBITDA was ₹1.49 Cr (13% margin).
- ₹11.43 CrRevenue · FY 2024
- ₹31.2 LakhNet profit · 3% margin
- ₹1.49 CrEBITDA · 13% margin
- ₹10 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Meha Pharma Private Limited are on its company page.
Detailed financial statements for Meha Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Industrial & Functional Materials
10 companies that operate in the same segment as Meha Pharma (Industrial & Functional Materials), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Major automotive components are manufactured and supplied by Hexion. | 2005 | Columbus, Ohio, United States | USD 15.26 M | – | – | |
Additives, silanes, and related formulations are manufactured globally. | 2010 | Schenectady, New York, United States | USD 804.95 K | USD 105.46 M | 491 | |
Pulp and paper products are manufactured by Suzano worldwide. | 1924 | Sao Paulo, Brazil | – | USD 9.15 B | 56,000 | |
Cellulose, biopackaging, and consumer tissue products are manufactured sustainably. | 1920 | Santiago, Region Metropolitana De Santiago, Chile | – | – | 15,490 | |
Chemicals, polymers, fabrics, and fibers are manufactured for apparel. | 2003 | Wichita, Kansas, United States | – | – | – | |
Paper and packaging products are manufactured for various applications. | 1888 | Verona, Veneto, Italy | – | – | – | |
Manufacturing of FIBC bags, container liners, and packaging solutions. | 2007 | Vadodara, Gujarat, India | – | USD 99.18 M | 615 | |
Colors and masterbatches are manufactured for industrial applications. | 1937 | Lambertville, United States | – | – | – | |
Packaging solutions and eco-friendly paper products are manufactured. | 2010 | Madawaska, Maine, United States | – | – | – | |
Acrylic fibers are produced by Pasupati Acrylon in India. | 1990 | Delhi, Delhi, India | – | USD 107.44 M | 514 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Meha Pharma
The primary company behind Meha Pharma, Meha Pharma Private Limited, reported revenue of ₹11.43 Cr for FY 2024.
Meha Pharma is identified as the largest manufacturer and exporter of antacid APIs in India, with facilities situated in Goa and an office in Mumbai. Products including antacid actives, excipients, and speciality chemicals are produced under cGMP conditions, serving pharmaceuticals, cosmetics, nutraceutical, and food industries across 22 countries. Customization for parameters like bulk density and particle size is offered, while solutions for formulation issues such as discoloration and settling are provided. Safety and efficacy standards are maintained by the company to meet regulatory expectations, focusing on high-quality materials for global markets.
Meha Pharma offers Antacid API and Excipients.
Meha Pharma operates through Meha Pharma Private Limited.
The legal entities of Meha Pharma currently have 2 directors, including Mamta Agarwal, Sanjay Kailashchandra Agarwal.